<?xml version="1.0" encoding="UTF-8"?>
<abstract abstract-type="author-highlights" id="ab005">
 <title>Highlights</title>
 <p>
  <list list-type="simple" id="l0005">
   <list-item id="o0005">
    <label>•</label>
    <p id="p0005">To investigate a multi-serotype disease alongside antibody-dependent-enhancement; ADE, this article is introducing two kinds of vaccination; primary and secondary vaccines.</p>
   </list-item>
   <list-item id="o0010">
    <label>•</label>
    <p id="p0010">Our framework dovetails mathematical epidemiological model; incorporating SVIRS epidemic model, with evolutionary decision dynamics.</p>
   </list-item>
   <list-item id="o0015">
    <label>•</label>
    <p id="p0015">The primary vaccine targets susceptible people, while the secondary one aims once infected but now recovered individuals letting them avoid ‘second infection’ which means critical situation.</p>
   </list-item>
   <list-item id="o0020">
    <label>•</label>
    <p id="p0020">We quantitatively argue, how effectively the primary and secondary vaccines to minimize such socially critical situation.</p>
   </list-item>
  </list>
 </p>
</abstract>
